Kathrin J. Scheidegger

635 total citations
11 papers, 543 citations indexed

About

Kathrin J. Scheidegger is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Kathrin J. Scheidegger has authored 11 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Cardiology and Cardiovascular Medicine and 3 papers in Physiology. Recurrent topics in Kathrin J. Scheidegger's work include Growth Hormone and Insulin-like Growth Factors (5 papers), Renin-Angiotensin System Studies (4 papers) and Hormonal Regulation and Hypertension (3 papers). Kathrin J. Scheidegger is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (5 papers), Renin-Angiotensin System Studies (4 papers) and Hormonal Regulation and Hypertension (3 papers). Kathrin J. Scheidegger collaborates with scholars based in Switzerland, United States and Netherlands. Kathrin J. Scheidegger's co-authors include Patrice Delafontaine, Marijke Brink, Susan Butler, Joseph L. Witztum, Jie Du, Hiroyuki Itabe, Yoshifumi Okura, Asif Anwar, Afksendiyos Kalangos and Richard W. James and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Kathrin J. Scheidegger

11 papers receiving 533 citations

Peers

Kathrin J. Scheidegger
Kathrin J. Scheidegger
Citations per year, relative to Kathrin J. Scheidegger Kathrin J. Scheidegger (= 1×) peers Yutaka Hisada

Countries citing papers authored by Kathrin J. Scheidegger

Since Specialization
Citations

This map shows the geographic impact of Kathrin J. Scheidegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin J. Scheidegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin J. Scheidegger more than expected).

Fields of papers citing papers by Kathrin J. Scheidegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin J. Scheidegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin J. Scheidegger. The network helps show where Kathrin J. Scheidegger may publish in the future.

Co-authorship network of co-authors of Kathrin J. Scheidegger

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin J. Scheidegger. A scholar is included among the top collaborators of Kathrin J. Scheidegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin J. Scheidegger. Kathrin J. Scheidegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Scheidegger, Kathrin J.. (2000). Differential effects of low density lipoproteins on IGF-1 and IGF-1R expression in vascular smooth muscle cells. Journal of Biological Chemistry. 20 indexed citations
3.
Scheidegger, Kathrin J., Bruno Cenni, Didier Picard, & Patrice Delafontaine. (2000). Estradiol Decreases IGF-1 and IGF-1 Receptor Expression in Rat Aortic Smooth Muscle Cells. Journal of Biological Chemistry. 275(49). 38921–38928. 54 indexed citations
4.
Okura, Yoshifumi, Marijke Brink, Hiroyuki Itabe, et al.. (2000). Oxidized Low-Density Lipoprotein Is Associated With Apoptosis of Vascular Smooth Muscle Cells in Human Atherosclerotic Plaques. Circulation. 102(22). 2680–2686. 99 indexed citations
5.
Scheidegger, Kathrin J., Richard W. James, & Patrice Delafontaine. (2000). Differential Effects of Low Density Lipoproteins on Insulin-like Growth Factor-1 (IGF-1) and IGF-1 Receptor Expression in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 275(35). 26864–26869. 48 indexed citations
6.
Scheidegger, Kathrin J., Jie Du, & Patrice Delafontaine. (1999). Distinct and Common Pathways in the Regulation of Insulin-like Growth Factor-1 Receptor Gene Expression by Angiotensin II and Basic Fibroblast Growth Factor. Journal of Biological Chemistry. 274(6). 3522–3530. 47 indexed citations
7.
Du, Jie, Tao Peng, Kathrin J. Scheidegger, & Patrice Delafontaine. (1999). Angiotensin II Activation of Insulin-Like Growth Factor 1 Receptor Transcription Is Mediated by a Tyrosine Kinase–Dependent Redox-Sensitive Mechanism. Arteriosclerosis Thrombosis and Vascular Biology. 19(9). 2119–2126. 56 indexed citations
8.
Scheidegger, Kathrin J., et al.. (1997). Structural adaptation to ischemia in skeletal muscle. Journal of Hypertension. 15(12). 1455–1461. 8 indexed citations
9.
Scheidegger, Kathrin J., Susan Butler, & Joseph L. Witztum. (1997). Angiotensin II Increases Macrophage-mediated Modification of Low Density Lipoprotein via a Lipoxygenase-dependent Pathway. Journal of Biological Chemistry. 272(34). 21609–21615. 99 indexed citations
10.
Scheidegger, Kathrin J. & Jeanette M. Wood. (1997). Local Application of Angiotensin II to the Rat Carotid Artery Induces Adventitial Thickening. Journal of Vascular Research. 34(6). 436–446. 11 indexed citations
11.
Scheidegger, Kathrin J., J M Wood, Helma van Essen, & H.A.J. Struijker-Boudier. (1996). Effects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats.. Journal of Pharmacology and Experimental Therapeutics. 278(3). 1276–1281. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026